PUD, GERD, IBD Flashcards
MOA of antacids
- neutralize gastric acid, raise pH >4
ADEs of antacids
- AlOH - constipation
- Mg products - diarrhea.
combo of Al and Mg is popular - Ca - tums
When to take antacids
1 hr and 3 hr after meal and at bedtime. Don’t take w/in 1-2 hr of other drugs.
MOA of H2 receptor antagonists
- inhibit all phases of gastric acid secretion
2. reduce both Volume and [H+] of gastric acid secretion
Potency of H2 Receptor antagonists
- cimetidine - 1
- Ranitidine : 4-10
- Nizatidine : 4-10
- Famotiding : 20-50
ADE of Cimetidine
- inhibits CYPs thus slows metabolism of many drugs
MOA of PPIs + how do they get to where they need to
- enteric coating allows release of pro-drug in gut, lipid solubility of PPIs permits absorption into bloodstream. PPIs then carried by blood to parietal cells and diffuse to acid pH causes protonation and trapping of drug near PP.
- Irreversible binding to HKATPase leads to Achlorhydria b/c all gastric acid secretion is blocked
Details about PPIs
- omeprazole and esomeprazole - long duration of action
- Lansoprazole - less effective in severe esophagitis
- Rabeprazole - less CYP metabolism
MOA of Bismuth Subsalicylate (pepto bismol)
- enhance secretion of mucus and HCO3
- inhibit pepsin activity
- chelates w/ proteins at base of ulcer, forms protective barrier against acid and pepsin
- inhibits H plyori
MOA of sucralfate
forms sticky, viscous gel that adheres to gastric epithelial cells protecting them from acid and pepsin
- only cytoprotective agent that needs an acidic pH for max activity
MOA of clarithromycin
macrolide, inhibits protein synthesis
MOA and CI of amoxcillin
effective against gram negative bacilli.
CI - pts allergic to penicillin
MOA of Metronidazole
synthetic Abx active against obligate anaerobes
MOA of furazolidine
nitrofuran antibacterial and antiprotozoal
H Pylori Abx resistance
- Clathriomycin - 8%
- Metro - 43%
- Amoxicillin - 3%
MOA of metoclopramide
D2 receptor antagonist; w/in GIT this increases local release of ACH via 5HT4 agonism.
- stimulates GI SM
- increases amplitude of esophageal contractions
- accelerates gastric emptying
- increases LES pressure
ADE of metoclopramide
Tardive dyskinesia
MOA of sulfasalazine
- 5 aminosalicylic acid derivative - acts as local anti-inflammatory agent.
- Broke down by intestinal bacteria to sulfapyridine and 5 aminosalicylic acid.
ADE of sulfasalazine
anemia, rash, and impotence
MOA of infliximab
MAB against TNF-alpha
MOa of etanercept
fusion protein containing ligand binding portion of TNF-alpha receptor linked to Fc portion of human IgG1.
MOA of neomycin
antibacterial givens as enema to reduce bacteria in colon for portal systemic encephalopathy
MOA of lactulose
semisynthetis disaccharide, fecal acidifer - retards nonionic diffusion of ammonia from colon to blood. osmotive laxative effect that discharges NH3